Register-based predictors of adherence among new statin users in Finland

Journal of Clinical Lipidology

Volumn 8, Issue 1, 2014, Pages 117-125

  Aarnio, Emma J ^a,b   Martikainen, Janne A ^b   Helin Salmivaara, Arja ^c,d   Huupponen, Risto K ^a,c   Hartikainen, Juha E K ^b,e   Peura, Piia K ^f   Korhonen, Maarit Jaana ^c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f Finnish Medicines Agency   (Finland)

Author keywords

Adherence; Dispensation delay; Explanatory model; Out of pocket costs; Register based study; Statins

Indexed keywords

ADHERENCE; DISPENSATION DELAY; EXPLANATORY MODEL; OUT-OF-POCKET COSTS; REGISTER-BASED STUDY; STATINS;

AGED; DELIVERY OF HEALTH CARE; FEMALE; FINLAND; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; REGISTRIES;

EID: 84893982479     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2013.09.008     Document Type: Article

References (33)

1. Cholesterol Treatment Trialists' (CTT) Collaboration C. Baigent, L. Blackwell, and J. Emberson et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
2. M. Lemstra, D. Blackburn, A. Crawley, and R. Fung Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis Can J Cardiol 28 2012 574 580
3. J.A. Cramer, A. Roy, and A. Burrell et al. Medication compliance and persistence: terminology and definitions Value Health 11 2008 44 47
4. A. Bitton, N.K. Choudhry, O.S. Matlin, K. Swanton, and W.H. Shrank The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review Am J Med 126 2013 357.e7 357.e27
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
6. World Health Organization (WHO). Adherence to long-term therapy: evidence for action; 2003. Available at: http://www.who.int/chp/knowledge/publications/ adherence-report/en/. Accessed August 21, 2012.
7. R.J. Simpson Jr., and P. Mendys The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review J Clin Lipidol 4 2010 462 471
8. K.A. Boswell, C.L. Cook, S.P. Burch, M.T. Eaddy, and C.R Cantrell Associating medication adherence with improved outcomes: a systematic literature review Am J Pharm Benefits 4 2012 e97 e108
9. D.C. Chan, W.H. Shrank, and D. Cutler et al. Patient, physician, and payment predictors of statin adherence Med Care 48 2010 196 202
10. D.M. Mann, J.P. Allegrante, S. Natarajan, E.A. Halm, and M. Charlson Predictors of adherence to statins for primary prevention Cardiovasc Drugs Ther 21 2007 311 316
11. A. Mauskop, and W.B. Borden Predictors of statin adherence Curr Cardiol Rep 13 2011 553 558
12. S. Baroletti, and H. Dell'Orfano Medication adherence in cardiovascular disease Circulation 121 2010 1455 1458
13. M.Y. Wei, M.K. Ito, J.D. Cohen, E.A. Brinton, and T.A. Jacobson Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education J Clin Lipidol 7 2013 472 483
14. A.P. Yu, Y.F. Yu, M.B. Nichol, and F. Gwadry-Sridhar Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistence Clin Ther 30 2008 761 774
15. A. Helin-Salmivaara, M.J. Korhonen, T. Alanen, and R. Huupponen Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland J Clin Pharm Ther 37 2012 58 64
16. N.K. Choudhry Copayment levels and medication adherence: less is more Circulation 119 2009 365 367
17. K. Furu, B. Wettermark, M. Andersen, J.E. Martikainen, A.B. Almarsdottir, and H.T. Sorensen The Nordic countries as a cohort for pharmacoepidemiological research Basic Clin Pharmacol Toxicol 106 2010 86 94
18. World Health Organization (WHO). ATC/DDD index 2013. Available at: http://www.whocc.no/atc-ddd-index/. Accessed June 3, 2013.
19. M. Peltola, M. Juntunen, U. Hakkinen, G. Rosenqvist, T.T. Seppala, and R. Sund A methodological approach for register-based evaluation of cost and outcomes in health care Ann Med 43 Suppl 1) 2011 S4 13
20. A.M. Peterson, D.P. Nau, J.A. Cramer, J. Benner, F. Gwadry-Sridhar, and M. Nichol A checklist for medication compliance and persistence studies using retrospective databases Value Health 10 2007 3 12
21. E. Lesen, T.Z. Sandstrom, A. Carlsten, A.K. Jonsson, A.C. Mardby, and K.A. Sundell A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project Pharmacoepidemiol Drug Saf 20 2011 1073 1079
22. S. Karve, M.A. Cleves, M. Helm, T.J. Hudson, D.S. West, and B.C. Martin Good and poor adherence: optimal cut-point for adherence measures using administrative claims data Curr Med Res Opin 25 2009 2303 2310
23. A. Meretoja, R.O. Roine, and T. Erilä et al. PERFECT - Stroke 2007 Stakes Helsinki, Finland Available at http://www.julkari.fi/handle/10024/75720 Accessed January 4, 2012
24. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
25. T.B. Gibson, T.L. Mark, K. Axelsen, O. Baser, D.A. Rublee, and K.A. McGuigan Impact of statin copayments on adherence and medical care utilization and expenditures Am J Manag Care 12 2006 SP11 SP19
26. D.P. Goldman, G.F. Joyce, and P. Karaca-Mandic Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy Am J Manag Care 12 2006 21 28
27. S. Schneeweiss, A.R. Patrick, M. Maclure, C.R. Dormuth, and R.J. Glynn Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment Circulation 115 2007 2128 2135
28. A. Pedan, L. Varasteh, and S. Schneeweiss Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics J Manag Care Pharm 13 2007 487 496
29. X. Ye, C.R. Gross, J. Schommer, R. Cline, and W.L. Peter St Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study Clin Ther 29 2007 2748 2757
30. J.S. Benner, M.F. Pollack, T.W. Smith, M.F. Bullano, V.J. Willey, and S.A. Williams Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy Am J Health Syst Pharm 62 2005 1468 1475
31. J.S. Benner, R.J. Glynn, H. Mogun, P.J. Neumann, M.C. Weinstein, and J. Avorn Long-term persistence in use of statin therapy in elderly patients JAMA 288 2002 455 461
32. J.F. Steiner Can we identify clinical predictors of medication adherence. and should we? Med Care 48 2010 193 195
33. M.J. Korhonen, A. Helin-Salmivaara, and R. Huupponen Dynamics of long-term statin therapy Eur J Clin Pharmacol 67 2011 925 931